[주저자 및 책임저자]

1. Won KB, et al. High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients. Korean Circ J 2012; 42: 335-340. 

2. Won KB, et al. Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes. Cardiovasc Diabetol 2013; 12: 41. 

3. Won KB, et al. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 2014; 83: 713-720. 

4. Won KB, et al. Prognostic usefulness of metabolic syndrome compared with diabetes in Korean patients with critical lower limb ischemia treated with percutaneous transluminal angioplasty. Yonsei Med J 2014; 55: 46-52. 

5. Won KB, et al. Safety and cost-effectiveness of bridge therapies for invasive dental procedures in patients with mechanical heart valves. Yonsei Med J 2014; 55: 937-943. 

6. Won KB, et al. Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population. BMC Cardiovasc Disord 2014; 14: 105. 

7. Won KB, et al. Differential association between obesity and coronary artery disease according to the presence of diabetes in a Korean population. Diabetol Metab Syndr 2014; 6: 134. 

8. Won KB, et al. Evaluation of the predictive value of coronary artery calcium score for obstructive coronary artery disease in asymptomatic Korean patients with type 2 diabetes mellitus. Coron Artery Dis 2015; 26: 150-156. 

9. Won KB, et al. Inverse association between central obesity and arterial stiffness in Korean subjects with metabolic syndrome: a cross-sectional cohort study. Diabetol Metab Syndr 2015; 7: 3. 

10. Won KB, et al. Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry. Cardiovasc Diabetol 2015; 14: 141. 

11. Won KB, et al. Clinical outcomes in patients with deferred coronary lesions according to disease severity assessed by fractional flow reserve. J Korean Med Sci 2016; 31: 1929-1936. 

12. Won KB, et al. Metabolic Syndrome predicts long-term mortality in subjects without established diabetes mellitus in asymptomatic Korean population: a propensity score matching analysis from the Korea Initiatives on Coronary Artery Calcification (KOICA) registry. Medicine (Baltimore) 2016; 95: e5421. 

13. Won KB, et al. Evaluation of the impact of statin therapy on the obesity paradox in patients with acute myocardial infarction: A propensity score matching analysis from the Korea Acute Myocardial Infarction Registry. Medicine (Baltimore) 2017; 96: e7180. 

14. Won KB, et al. Comparison of long-term mortality according to obesity in patients with successful percutaneous chronic total occlusion interventions using drug-eluting stents. Catheter Cardiovasc Interv 2018; 91: 710-716. 

15. Won KB, et al. Evaluation of the impact of glycemic status on the progression of coronary artery calcification in asymptomatic individuals. Cardiovasc Diabetol 2018; 17: 4. 

16. Won KB, et al. The relationship of insulin resistance estimated by triglyceride glucose index and coronary plaque characteristics. Medicine (Baltimore) 2018; 97: e10726. 

17. Won KB, et al. Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes. Int J Cardiol 2018; 266: 250-253. 

18. Won KB, et al. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis 2018; 17: 268. 

19. Won KB, et al. Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy. J Cardiovasc Comput Tomogr 2019; 13: 142-147. 

20. Won KB, et al. Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging 2019; 20: 591-599. 

21. Won KB, et al. Independent role of low-density lipoprotein cholesterol in subclinical coronary atherosclerosis in the absence of traditional cardiovascular risk factors. Eur Heart J Cardiovasc Imaging 2019; 20: 866-872. 

22. Cho YR, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep 2019; 9: 6129. 

23. Yang YJ, et al. Relationship between the optimal cut-off values of anthropometric indices for predicting metabolic syndrome and carotid intima-medial thickness in a Korean population. Medicine (Baltimore) 2019; 98: e17620. 

24. Park GM, et al. High HDL-C levels reduce the risk of obstructive coronary artery disease in asymptomatic diabetics who achieved optimal glycemic control. Sci Rep 2019; 9: 15306. 

25. Park GM, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis 2020; 19: 7. 

26. Won KB, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol 2020; 19: 34. 

27. Kim YG, et al. High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individuals. Eur J Prev Cardiol 2020; 27: 706-714. 

28. Won KB, et al. Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. Cardiovasc Diabetol. 2020; 19: 113. 

29. Won KB, et al. Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: An observational cohort study. Clin Cardiol. 2020; 43: 1398-1404. 

30. Won KB, et al. Atherogenic index of plasma and coronary artery calcification progression beyond traditional risk factors according to baseline coronary artery calcium score. Sci Rep. 2020; 10: 21324. 

31. Won KB, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis 2021; 324: 46-51. 

32. Won KB, et al. Association between blood pressure classification defined by the 2017 ACC/AHA guidelines and coronary artery calcification progression in an asymptomatic adult population. Eur Heart J Open 2021; 1: oeab009. 

33. Won KB, et al. Longitudinal Quantitative Assessment of Coronary Atherosclerotic Plaque Burden Related to Serum Hemoglobin Levels. JACC Asia 2022; 2: 311-319. 

34. Won KB, et al. Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry. Cardiovasc Diabetol 2022; 21: 239. 

35. Won KB, et al. Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease. Clin Cardiol 2022; 45: 873-881. 

36. Won KB, et al. Body Mass Index and Major Adverse Events During Chronic Antiplatelet Monotherapy After Percutaneous Coronary Intervention With Drug-Eluting Stents - Results From the HOST-EXAM Trial. Circ J 2023; 87: 268-276. 

37. Won KB, et al. Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity. J Clin Med 2023; 12: 3770.

38. Won KB, et al. Different association of atherogenic index of plasma with the risk of high platelet reactivity according to the presentation of acute myocardial infarction. Sci Rep 2024; 14: 10894.

39. Won KB, et al. Different associations of atherogenic index of plasma, triglyceride glucose index, and hemoglobin A1C levels with the risk of coronary artery calcification progression according to established diabetes. Cardiovasc Diabetol 2024; 23: 418.

40. Won KB, et al. Sex difference in the risk of coronary artery calcification progression related to hyperuricemia among asymptomatic 12,316 Korean adults. Sci Rep 2024; 14: 28710.

41. Won KB, et al. Longitudinal assessment of serum albumin levels with the risk of coronary artery calcification progression in an asymptomatic population of Korean adults: an observational cohort study. BMJ Open 2024; 14: e086075.

[공동저자]

1. Lee YK, et al. The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium. J Korean Med Sci 2009; 24: S189-194. 

2. Hur SH, et al. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR). Clin Cardiol 2016; 39: 276-84. 

3. Kim H, et al. Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy. Heart 2016; 102: 1215-1220. 

4. Hur SH, et al. Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study. Medicine (Baltimore) 2016; 95: e3882. 

5. Park GM, et al. Prediabetes is not a risk factor for subclinical coronary atherosclerosis. Int J Cardiol 2017; 243: 479-484. 

6. Kim YS, et al. Extracorporeal Cardiopulmonary Resuscitation with Therapeutic Hypothermia for Prolonged Refractory In-hospital Cardiac Arrest. Korean Circ J 2017; 47: 939-948. 

7. Kim YG, et al. Metabolic Syndrome and the Risk of New-Onset Atrial Fibrillation in Middle-Aged East Asian Men. Circ J 2018; 82: 1763-1769. 

8. Kim SJ, et al. A Case of Unroofed Coronary Sinus with Coronary Sinus Orifice Atresia: Use of Multimodality Imaging. J Cardiovasc Imaging 2018; 26: 103-105. 

9. Han S, et al. Effect of atrial fibrillation in Asian patients undergoing percutaneous coronary intervention with drug-eluting stents for stable coronary artery disease: Results from a Korean nationwide study. Medicine (Baltimore) 2018; 97: e13488. 

10. Yang Y, et al. Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study. PLoS One 2018; 13: e0208746. 

11. Park MW, et al. Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis. PLoS One 2018; 13: e0207889. 

12. Ann SH, et al. Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. Int J Cardiol. 2020; 306: 35-41. 

13. Park GM, et al. Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography Registry. Diabetes Metab J. 2020; 44: 470-479. 

14. Lee C, et al. Severity, Progress, and Related Factors of Mood Disorders in Patients with Coronary Artery Disease: A Retrospective Study. Healthcare (Basel). 2020; 8:568. 

15. Kang HH, et al. Independent association of serum uric acid levels with arterial stiffness in the absence of established cardiovascular disorders. Int J Clin Pract. 2021; 75: e13720. 

16. Choi Y, et al. Association of serum hemoglobin level with the risk of carotid plaque beyond metabolic abnormalities among asymptomatic adults without major adverse clinical events: a cross-sectional cohort study. BMC Cardiovasc Disord. 2021; 21: 35. 

17. Han S, et al. Comparison of new implantation of cardiac implantable electronic device between tertiary and non-tertiary hospitals: a Korean nationwide study. Sci Rep. 2021; 11: 3705. 

18. Kim RB, et al. Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers. J Clin Med. 2021; 10: 498. 

19. Koo BK, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet. 2021; 397(10293): 2487-2496. 

20. Ki YJ, et al. Prasugrel-based de-Escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with STEMI. Korean Circ J. 2022; 52(4):e18. 

21. Jin U, et al. Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical Trial. J Invasive Cardiol 2022; 34: E653-E659. 

22. Yun JP, et al. Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function. JACC Asia 2023; 3: 51-61. 

23. Kumar S, et al. Stent underexpansion is associated with high wall shear stress: a biomechanical analysis of the shear stent study. Int J Cardiovasc Imaging 2023; 39: 1375-1382. 

24. Shin ES, et al. Association of Clinical Outcomes With Sex in Patients Receiving Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: A Post Hoc Gender Analysis of the HOST-EXAM Study. J Am Heart Assoc 2023; 12: e026770.